Melbourne-based EBS secures FDA Approval for World-First Leadless Wise CRT System
Posted: 14th April 2025 Melbourne-based organisation EBR Systems proudly announces that the U.S. Food and Drug Administration (FDA) has granted approval for its WiSE® CRT System. This groundbreaking system is the world’s first and only leadless solution for…
MoU signed between St Vincent’s Hospital Melbourne and Sichuan Provincial People’s Hospital Enhances Research Collaboration with China
Posted: 10th April 2025 St Vincent’s Hospital Melbourne has signed a Memorandum of Understanding (MoU) with Sichuan Provincial People’s Hospital in China, marking a significant step in advancing international clinical research and innovation. The MoU was signed during…
Monash University’s $7 Million Grant to Improve Atrial Fibrillation Treatment in Australia
Posted: 10th April 2025 In a significant step forward for cardiac care, Monash University has announced a $7 million grant to establish Australia’s first clinical quality registry for atrial fibrillation (AF) ablation. This initiative aims to enhance treatment…
Florey Researchers Secure $4.9 Million Grant for Promising New Heart Surgery Treatment
Posted: 10th April 2025 The Florey Institute of Neuroscience and Mental Health, in collaboration with the University of Melbourne, has been awarded a $4.9 million grant from the Australian Government’s Medical Research Future Fund (MRFF) to develop a…
Launch of ANDHealth State of the Industry Report- “The Rising Giant”
ANDHealth’s latest state of the industry report reveals substantive data on the status, expansion and maturation of the Australian health sector and its role as a significant player in the global digital health landscape. The report highlights significant…
Strength in Synergy: BioForum focused on building resilience in the face of biothreats
In today’s globally-connected world, biological threats – whether naturally occurring, accidental, or deliberately engineered – pose an escalating risk to public health, economic resilience and national security. Confronting these challenges requires more than expertise; it demands true synergy…
Atmo Biosciences announces publication of pivotal clinical study results supporting initial indication
Posted: 6 March 2025 Today, Atmo Biosciences announced the publication of pivotal clinical study data in Clinical Gastroenterology and Hepatology. The study validates the Atmo Capsule for assessing whole and regional gastrointestinal transit times to assist with the…
BioMelbourne Network announces new Board Chair appointment
Posted: 6 March 2025 BioMelbourne Network, the peak industry body for the life sciences sector in Victoria, announces that its Chair, David Herd, will retire from the Board on 28 April 2025. The Board has elected Dr Emma…
2025 BioSymposium Agenda: Innovations in technologies – Implantables, Neurotech and Diagnostics
Tuesday 25 March 2025 | 8:30 AM – 6:00 PM AEDT 08:30 AM Guest arrival and registration
Institute appoints Deputy Directors to lead with heart
Posted: 4 March 2025 The Victorian Heart Institute (VHI) has announced the appointment of three Deputy Directors to support the Institute’s leadership as it continues to drive innovation in cardiovascular research, education, prevention and care. Professor Francine Marques (Deputy…
Bold vision to transform the health and wellbeing of children in Australia
Posted: 4 March 2025 Two of the largest studies of their kind in Australia have a bold vision to come together to transform the health and wellbeing of children now and for future generations. GenV, tracking the health…
